Infectious diseases and the impact on transfusion medicine: a historical review and lessons for the future
This study aims to review historically the principal infectious diseases transmitted through the blood that circulated worldwide in the 20th and 21st centuries, considering the impact on the blood banks. Despite the current blood bank control of transfusion risks and the hemovigilance improvements, transmitted and emerging infections can still compromise the blood bank supply, as we have witnessed during the first waves of the COVID-19 pandemic. Moreover, new pathogens will continue emerging, and we must be prepared for the future.PMID:37328129 | DOI:10.1016/j.tracli.2023.06.004 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 16, 2023 Category: Hematology Authors: Val éria de Freitas Dutra Carolina Bonet-Bub Araci Massami Sakashita Jos é Mauro Kutner Source Type: research
Infectious diseases and the impact on transfusion medicine: a historical review and lessons for the future
This study aims to review historically the principal infectious diseases transmitted through the blood that circulated worldwide in the 20th and 21st centuries, considering the impact on the blood banks. Despite the current blood bank control of transfusion risks and the hemovigilance improvements, transmitted and emerging infections can still compromise the blood bank supply, as we have witnessed during the first waves of the COVID-19 pandemic. Moreover, new pathogens will continue emerging, and we must be prepared for the future.PMID:37328129 | DOI:10.1016/j.tracli.2023.06.004 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 16, 2023 Category: Hematology Authors: Val éria de Freitas Dutra Carolina Bonet-Bub Araci Massami Sakashita Jos é Mauro Kutner Source Type: research
Infectious diseases and the impact on transfusion medicine: a historical review and lessons for the future
This study aims to review historically the principal infectious diseases transmitted through the blood that circulated worldwide in the 20th and 21st centuries, considering the impact on the blood banks. Despite the current blood bank control of transfusion risks and the hemovigilance improvements, transmitted and emerging infections can still compromise the blood bank supply, as we have witnessed during the first waves of the COVID-19 pandemic. Moreover, new pathogens will continue emerging, and we must be prepared for the future.PMID:37328129 | DOI:10.1016/j.tracli.2023.06.004 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 16, 2023 Category: Hematology Authors: Val éria de Freitas Dutra Carolina Bonet-Bub Araci Massami Sakashita Jos é Mauro Kutner Source Type: research
Infectious diseases and the impact on transfusion medicine: a historical review and lessons for the future
This study aims to review historically the principal infectious diseases transmitted through the blood that circulated worldwide in the 20th and 21st centuries, considering the impact on the blood banks. Despite the current blood bank control of transfusion risks and the hemovigilance improvements, transmitted and emerging infections can still compromise the blood bank supply, as we have witnessed during the first waves of the COVID-19 pandemic. Moreover, new pathogens will continue emerging, and we must be prepared for the future.PMID:37328129 | DOI:10.1016/j.tracli.2023.06.004 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 16, 2023 Category: Hematology Authors: Val éria de Freitas Dutra Carolina Bonet-Bub Araci Massami Sakashita Jos é Mauro Kutner Source Type: research
Infectious diseases and the impact on transfusion medicine: a historical review and lessons for the future
This study aims to review historically the principal infectious diseases transmitted through the blood that circulated worldwide in the 20th and 21st centuries, considering the impact on the blood banks. Despite the current blood bank control of transfusion risks and the hemovigilance improvements, transmitted and emerging infections can still compromise the blood bank supply, as we have witnessed during the first waves of the COVID-19 pandemic. Moreover, new pathogens will continue emerging, and we must be prepared for the future.PMID:37328129 | DOI:10.1016/j.tracli.2023.06.004 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 16, 2023 Category: Hematology Authors: Val éria de Freitas Dutra Carolina Bonet-Bub Araci Massami Sakashita Jos é Mauro Kutner Source Type: research
Infectious diseases and the impact on transfusion medicine: a historical review and lessons for the future
This study aims to review historically the principal infectious diseases transmitted through the blood that circulated worldwide in the 20th and 21st centuries, considering the impact on the blood banks. Despite the current blood bank control of transfusion risks and the hemovigilance improvements, transmitted and emerging infections can still compromise the blood bank supply, as we have witnessed during the first waves of the COVID-19 pandemic. Moreover, new pathogens will continue emerging, and we must be prepared for the future.PMID:37328129 | DOI:10.1016/j.tracli.2023.06.004 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 16, 2023 Category: Hematology Authors: Val éria de Freitas Dutra Carolina Bonet-Bub Araci Massami Sakashita Jos é Mauro Kutner Source Type: research
Infectious diseases and the impact on transfusion medicine: a historical review and lessons for the future
This study aims to review historically the principal infectious diseases transmitted through the blood that circulated worldwide in the 20th and 21st centuries, considering the impact on the blood banks. Despite the current blood bank control of transfusion risks and the hemovigilance improvements, transmitted and emerging infections can still compromise the blood bank supply, as we have witnessed during the first waves of the COVID-19 pandemic. Moreover, new pathogens will continue emerging, and we must be prepared for the future.PMID:37328129 | DOI:10.1016/j.tracli.2023.06.004 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 16, 2023 Category: Hematology Authors: Val éria de Freitas Dutra Carolina Bonet-Bub Araci Massami Sakashita Jos é Mauro Kutner Source Type: research
A Comparative Evaluation of the Quality of Cryoprecipitate Prepared from 350 ml Versus 450 ml of Whole Blood and Different Methods of Thawing of Plasma: A Prospective Observational Study
CONCLUSION: Over 75% of the cryoprecipitates prepared from 350 ml whole blood passed the fibrinogen and factor VIII quality control criteria. So, 350ml whole blood collection from low body weight (<55 kg) donors could be utilized to prepare cryoprcipitates. However, future clinical studies should focus on the cryoprecipitate's clinical efficacy prepared from 350 ml of whole blood.PMID:37321533 | DOI:10.1016/j.tracli.2023.06.002 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 15, 2023 Category: Hematology Authors: M Sree Bhgavathi Satya Prakash Gaurav Chhabra Ansuman Sahu Debasish Mishra Somnath Mukherjee Source Type: research
Comparison of restrictive and liberal red blood cell suspension transfusion and analysis of influencing factors on prognosis of premature infants
CONCLUSION: Compared with the restrictive transfusion group, liberal transfusion patients presented a shorter duration of ventilatory support, which is more beneficial to the prognosis of premature infants.PMID:37321534 | DOI:10.1016/j.tracli.2023.06.001 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 15, 2023 Category: Hematology Authors: Zhi Zeng Yu-Dan Chen Ming-Wei Yin Xue-Jun Chen Ting Wang Jun Xu Ji-Hua Ma Source Type: research
A Comparative Evaluation of the Quality of Cryoprecipitate Prepared from 350 ml Versus 450 ml of Whole Blood and Different Methods of Thawing of Plasma: A Prospective Observational Study
CONCLUSION: Over 75% of the cryoprecipitates prepared from 350 ml whole blood passed the fibrinogen and factor VIII quality control criteria. So, 350ml whole blood collection from low body weight (<55 kg) donors could be utilized to prepare cryoprcipitates. However, future clinical studies should focus on the cryoprecipitate's clinical efficacy prepared from 350 ml of whole blood.PMID:37321533 | DOI:10.1016/j.tracli.2023.06.002 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 15, 2023 Category: Hematology Authors: M Sree Bhgavathi Satya Prakash Gaurav Chhabra Ansuman Sahu Debasish Mishra Somnath Mukherjee Source Type: research
Comparison of restrictive and liberal red blood cell suspension transfusion and analysis of influencing factors on prognosis of premature infants
CONCLUSION: Compared with the restrictive transfusion group, liberal transfusion patients presented a shorter duration of ventilatory support, which is more beneficial to the prognosis of premature infants.PMID:37321534 | DOI:10.1016/j.tracli.2023.06.001 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 15, 2023 Category: Hematology Authors: Zhi Zeng Yu-Dan Chen Ming-Wei Yin Xue-Jun Chen Ting Wang Jun Xu Ji-Hua Ma Source Type: research
CAR-T Cell Therapy in India: Challenges and Opportunities for Advancement
Transfus Clin Biol. 2023 Jun 7:S1246-7820(23)00065-4. doi: 10.1016/j.tracli.2023.05.001. Online ahead of print.NO ABSTRACTPMID:37295552 | DOI:10.1016/j.tracli.2023.05.001 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 9, 2023 Category: Hematology Authors: Tarun Kumar Suvvari Vinay Suresh Krish Patel Ananya Arora Aman Bhonsale Rahul Jena Vivek Sanker Source Type: research
CAR-T Cell Therapy in India: Challenges and Opportunities for Advancement
Transfus Clin Biol. 2023 Jun 7:S1246-7820(23)00065-4. doi: 10.1016/j.tracli.2023.05.001. Online ahead of print.NO ABSTRACTPMID:37295552 | DOI:10.1016/j.tracli.2023.05.001 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 9, 2023 Category: Hematology Authors: Tarun Kumar Suvvari Vinay Suresh Krish Patel Ananya Arora Aman Bhonsale Rahul Jena Vivek Sanker Source Type: research
CAR-T Cell Therapy in India: Challenges and Opportunities for Advancement
Transfus Clin Biol. 2023 Jun 7:S1246-7820(23)00065-4. doi: 10.1016/j.tracli.2023.05.001. Online ahead of print.NO ABSTRACTPMID:37295552 | DOI:10.1016/j.tracli.2023.05.001 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 9, 2023 Category: Hematology Authors: Tarun Kumar Suvvari Vinay Suresh Krish Patel Ananya Arora Aman Bhonsale Rahul Jena Vivek Sanker Source Type: research
CAR-T Cell Therapy in India: Challenges and Opportunities for Advancement
Transfus Clin Biol. 2023 Jun 7:S1246-7820(23)00065-4. doi: 10.1016/j.tracli.2023.05.001. Online ahead of print.NO ABSTRACTPMID:37295552 | DOI:10.1016/j.tracli.2023.05.001 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - June 9, 2023 Category: Hematology Authors: Tarun Kumar Suvvari Vinay Suresh Krish Patel Ananya Arora Aman Bhonsale Rahul Jena Vivek Sanker Source Type: research
